Back to search

Article

Low-abundance αSyn-112 promotes αSyn-140 aggregation in vitro and forms immunoreactive deposits in Parkinson’s disease brain tissue

2026-07-09

Abstract excerpt

The aggregation of α-synuclein (αSyn) is a molecular hallmark of Parkinson’s disease (PD) and other synucleinopathies. Understanding the molecular mechanisms that determine the aggregation of this protein may thus facilitate the development of disease-modifying therapies. While αSyn is most commonly expressed as a 140-residue protein (αSyn-140), recent evidence suggests an involvement of alternatively spliced αSyn...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4db22a43-bf7e-5cbe-abe9-57d9d24b90b7
DOI
10.64898/2026.07.05.736591
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low-abundance αSyn-112 promotes αSyn-140 aggregation in vitro and forms immunoreactive deposits in Parkinson’s disease brain tissueDOI 10.64898/2026.07.05.736591
Select a neighboring publication to make it the new centre.